PD-L1 in blood
Jump to navigation
Jump to search
Indications
- predictive biomarker for checkpoint immunotherapy in NSCLC & other malignancies
- may be useful for treatment selection
- may be useful for monitoring response to treatment[1]
Procedure
- PD-L1 testing by immunohistochemistry
More general terms
Additional terms
References
- ↑ Jump up to: 1.0 1.1 Fuerst ML with critique by Bowman AI Blood Test Appears to Enable Immunotherapy Selection, Monitoring - Allows repeat testing, timely monitoring, and has potential to improve adherence to NCCN guidelines. MedPage Today. ASCO Reading Room 05.31.2018 https://www.medpagetoday.com/reading-room/asco/immunotherapy/73187
- ↑ ARUP Consult: PD-L1 Testing The Physician's Guide to Laboratory Test Selection & Interpretation https://arupconsult.com/content/pd-l1-testing
PD-L1 Testing Algorithm https://arupconsult.com/algorithm/pd-l1-testing-algorithm